AIM ImmunoTech (AIM) Gross Margin (2010 - 2026)
AIM ImmunoTech's Gross Margin came in at 80.77% for Q2 2026, up 20.77 percentage points from 60.00% a year earlier but down 1.05 percentage points from the prior quarter.
Powered by 
Analysis
AIM ImmunoTech (AIM) Gross Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AIM ImmunoTech reported Gross Margin of -23.16%, down 94.23 percentage points year-over-year; for FY2025, it came in at -45.45%, down 127.22 percentage points from FY2024.
- Gross Margin carries a five-year change of +349.02 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 81.76% in FY2024 (+2.56 pp), 79.21% in FY2023 and -529.63% in FY2021 (-135.15 pp).
- The five-year range for quarterly Gross Margin is -375.76% (Q3 2021) to 84.44% (Q4 2024).
- Year-over-year, Gross Margin increased in four of the last eight quarters, with an average year-over-year change of -46.22 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q2 2022 (a gain of 983.04 percentage points), and the weakest in Q3 2025 (a drop of 238.68 percentage points).
- Business Quant data shows AIM's Gross Margin at 81.82% (Q1 2026), -90.48% (Q4 2025) and -161.54% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 85.33% |
| 10 | AIM ImmunoTech | 2.91 Mn | -18.39 Mn | 21,000.00 | 80.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 80.77% |
| Mar 31, 2026 | 81.82% |
| Dec 31, 2025 | -90.48% |
| Sep 30, 2025 | -161.54% |
| Jun 30, 2025 | 60.00% |
| Mar 31, 2025 | 37.50% |
| Dec 31, 2024 | 84.44% |
| Sep 30, 2024 | 77.14% |
| Jun 30, 2024 | 84.00% |
| Mar 31, 2024 | 80.00% |
| Dec 31, 2023 | 81.54% |
| Sep 30, 2023 | 34.78% |
| Jun 30, 2022 | -130.00% |
| Mar 31, 2022 | -133.33% |
| Dec 31, 2021 | -252.00% |
| Sep 30, 2021 | -375.76% |
| Jun 30, 2021 | -1,113.04% |
| Mar 31, 2021 | -746.43% |
| Dec 31, 2020 | -371.43% |
| Sep 30, 2020 | -466.67% |
API Access
AIM ImmunoTech Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();